Drug linked to 33 deaths in Northern Ireland is reclassified
The prescription drug pregabalin is now being treated as a class C drug...
List view / Grid view
The prescription drug pregabalin is now being treated as a class C drug...
19 December 2014 | By Pfizer
Pfizer Inc. (NYSE:PFE) announced today top-line results from a double-blind Phase 3 study evaluating pregabalin controlled-release (CR) formulation in adult patients with postherpetic neuralgia (pain after shingles or PHN).
The study met its primary endpoint, showing a statistically significant greater reduction in fibromyalgia pain...
19 November 2012 | By Pfizer
Top-line results of a Phase 3 study...
16 November 2012 | By Pfizer
Pfizer Inc., announced top-line results of a double-blind, placebo-controlled, Phase 3 study...
19 July 2012 | By Pfizer
“The Court’s decision recognizes the infringement & validity of our LYRICA® patents..."
18 May 2012 | By Pfizer
Results of studies on Lyrica® announced...
4 May 2012 | By Pfizer
Pfizer has stopped a Phase 3 clinical trial of Lyrica in patients with neuropathic pain...
4 May 2012 | By Pfizer
Pfizer announced that a Phase 3 randomized withdrawal design study for Lyrica in patients...
5 July 2011 | By Pfizer
Pfizer Japan announced the top-line results for Lyrica (pregabalin) Study A0081208...
21 June 2011 | By Pfizer
Pfizer Inc. announced that top-line results for Lyrica Study A0081107, demonstrated that the study met its primary endpoint...